This morning, $TCNNF completed its acquisition of $HRVSF. A big moment for the company, and congrats to @rivers_kim and team for closing the deal in under 5 months. Some highlights and thoughts from their call this morning:
...
1. PF company is the largest and most profitable MSO (by a small amount on revenue and by a meaningful amount on Adj. EBITDA) 2. PF Company has 149 stores (37% more than nearest comp) and 3.1mm sq. ft. of cultivation (~2mm is in FL) 3. Core markets: FL, AZ, PA
...
4. The biggest new (and positive) thing on the call was that the PA regulator did not require any divestitures. The PF company will have 15/16 open stores in PA with the opportunity to have up to 21 stores. They will also hold 3 cultivation licenses
...
5. For those who haven't been following, Trulieve has gone from no presence in PA to being the largest retail operator (with a growing cultivation footprint) in under one year
...
6. I read this as a positive for the other MSOs in PA as well. There were signs the PA regulator was looking at "caps" differently than investors were, but their blessing of the Harvest deal is the biggest validation that MSOs likely have more runway in PA
...
7. That said, I continue to be a little cautious on PA's competitive dynamics. MSOs prepping for AU which would be a big tailwind for everyone, but until then, we could see pressure ratchet up
...
8. $TCNNF working on re-branding all acquired stores to "Trulieve." Company also talked up Harvest's brand portfolio and the opportunity to integrate them into Trulieve's footprint
...
9. Last night $TCNNF announced it raised $350mm of 8% sr. notes. Excellent paper. Company will be retiring $240mm of Harvest debt. PF company will be well capitalized going forward
...
10. FL: discounting pressure has been well-chronicled over the past qtr. Apparently, Harvest accelerated discounting recently to shed inventory to avoid taking an accounting markdown. I need to think through this a bit more, but I think the point is some price pressure...
...will ease (bc Harvest now part of Trulieve), but there are other players discounting and that is likely to continue in the near-term 11. Trulieve will provide PF guide on 4Q call (so Feb/Mar 22). Did say opex as % of sales shouldn't change materially
...
12. I wouldn't be surprised to see $TCNNF make a move in NJ. NJ is going to be one of the focal points of 2022 for investors and several MSOs have a presence in the state
In summary, big day for Trulieve. PF Co has major scale in FL, AZ, and PA with a growing presence in other states. PF financial profile will look strong. While no NJ presence means Co won't get that bump in 2022, when FL/PA go rec, $TCNNF is going to be a lead horse.
End.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1. Revs/AEBITDA of $91.3m/$27.4m vs. est. of $90.7m/$27.7m. Basically in-line; small misses on AEBITDA and margin 2. Adj. GMs and AEBITDA margins down 40bps/140bps QoQ. Some changes to GM calc that lifted #s
...
3. Guidance in focus. 3Q guide of $100mm revs and flat AEBITDA might've left some folks a little disappointed, but this was always going to be a 2022 story. 3Q guide incl. a little of NJ, anticipating acq close in 3Q. So, Co guiding to muted QoQ organic growth in 3Q...
4. While 3Q a little muted, Company raised 22 guide to $800m/$300m revs/AEBITDA vs. $725m/$300m previously. The jump in revs partly attributable to recent acquisitions (IL, NV, Levia bevs). Flat AEBITDA guidance implies some further investment. Could also suggest competition
...
1. Revs/AEBITDA of $215.1m/$94.9m vs est. of $205m/$92m. Solid beats. 44% AEBITDA margins 2. Real story around gross margin. GMs compressed 300bps from 70% in 1Q21 to 67% in 2Q21
...
3. Company cited 2 main factors in FL: a) price discounts in response to competitors aggressive actions and b) tighter labor markets. CFO said without these two factors, GMs would've been 71%. Glad they quantified it, but I'd take the 71% with a grain of salt...
...given it feels like some of these pricing dynamics could linger for a while. Kim mentioned the discounting started in back-half of 2Q, then eased, and has now picked back up. She also said its not always the same player(s) discounting. Seems to be rolling behavior...
1. Revenue and AEBITDA of $222m/$79.3 vs. $207m/$74.3m estimate (unadj. EBITDA down slightly QoQ). Nice beat on topline.
...
2. GMs were 55.4%, down 160bps QoQ driven by investments in cultivation and brand distribution. CFO said these investments will continue. Company focused on keeping GMs above 50% level, but sounds like excess will be reinvested for foreseeable future (not much upside NT)
...
3. CPG and retail grew 13%/15% QoQ. Over time we should expect to see CPG grow faster and become a bigger part of the mix. Company mentioned spending more cash on brand investments.
...
1. Revs and AEBITDA of $199m/$81m vs. est. of $188m/$81.5m. GMs declined to 50%, and unadj. EBITDA margin was 26% and AEBITDA margin was 41% 2. Lots to unpack in the report, incl some one-time impacts from M&A and accounting changes
...
3. First, on 1Q call company guided to "near" $200mm in revs for 2Q, and said unadj EBITDA margins should be in low-40s range with some potential volatility as acquisitions are integrated. By this measure, Company did what they said on revs, and EBITDA indeed showed some vol
...
4. I was impressed by how mgmt tackled the margin issue head on and appreciated them quantifying the various impacts:
- 300bps from inv. step-up (1x)
- 300bps from accounting treatment of change in cultivation practices (1x?)
- 200bps from Agrikind acq. slipping from 2Q to 3Q
...
1. Revenue and AEBITDA of $312m and $84m vs. est. of $308m and $83.3m. Unclear if est. included the $5mm of EMMAC revs 2. EBITDA margins showed nice sequential improvement (total +300bps; US-only +400bps). GMs also up
...
3. 27% total EBITDA margin on track to hit 30% guidance in 4Q. Sounds like GM upside more muted in near term 4. Left 2021 guide unch. Some conservatism, perhaps 5. $CURLF has $100mm annualized revs in 5 states w/ 2 more joining that group soon
...
6. Expects NJ to start AU sales in 4Q, CT to start AU in 2Q22, and NY to start AU in 2023 (echoing $GTBIF) 7. Expect PA and MD to legalize AU by 2023. This would be a boon to several operators
...
1. Company beat on revs by 4.5% but missed on EBITDA by 24%. Miss was driven by investments in cultivation and operating platform as well as transition to GAAP 2. GMs were 49% while EBITDA margin was 19.6%, below expectations
...
3. Margins are the key focus area this qtr. Big miss relative to consensus, but the Company guided for 30%+ EBITDA margins by 4Q21 as cultivation ramps in 2H21, generating operating leverage. Believable, but it puts $CRLBF in "show me" territory over the course of the year
...
4. Speaking of cultivation, Company plans to bring online capacity in MA, OH, FL, and MI. Commentary suggests we will see incremental growth in 2Q and 3Q with a bigger pop in 4Q and into 2022
...